Imatinib Mesylate: Medgend

Imatinib Mesylate FDA Approved Drugs

GLEEVEC [Imatinib Mesylate^{C₂₉H₃₁N₇OCH₄O₃S}]

eq 100mg base (oral tablet)

eq 400mg base (oral tablet)

Novartis^{Apr 18, 2003}

A method for treating a tumor disease.
Gleevec is also indicated for the treatment of patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (gist).
Treatment of gastrointestinal stromal tumors (gist).

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

IMATINIB MESYLATE [Imatinib Mesylate^{C₂₉H₃₁N₇OCH₄O₃S}]

eq 100mg base (oral tablet)

eq 400mg base (oral tablet)

Apotex Inc^{Aug 5, 2016}
Mylan Pharms Inc^{Jun 21, 2017}
Sun Pharma Global^{Dec 3, 2015}
Teva Pharms Usa^{Aug 4, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.